54
Participants
Start Date
December 20, 2016
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Atezolizumab
Gemcitabine
Cisplatin
New York University, New York
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Westchester, Harrison
Memorial Sloan Kettering Nassau, Uniondale
Memorial Sloan Kettering Commack, Commack
Lehigh Valley Health Network, Allentown
Ohio State University, Columbus
Hartford Healthcare Cancer Institute @ Hartford Hospital, Hartford
Memorial Sloan Kettering Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale
Collaborators (1)
Genentech, Inc.
INDUSTRY
Memorial Sloan Kettering Cancer Center
OTHER